(2S)-2-[3-(methoxymethoxy)phenyl]-3-phenylmethoxypropane-1,2-diol | 1170721-79-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2S)-2-[3-(methoxymethoxy)phenyl]-3-phenylmethoxypropane-1,2-diol
• CAS: 1170721-79-5
• 化学式: C₁₈H₂₂O₅
• 分子量: 318.37
• InChiKey: DGNNPSKOSMOHJL-SFHVURJKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  23
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  68.2
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (2S)-2-[3-(methoxymethoxy)phenyl]-3-phenylmethoxypropane-1,2-diol 、 叔丁基二甲基氯硅烷 在 咪唑 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以75%的产率得到(R)-1-(benzyloxy)-3-((tert-butyldimethylsilyl)oxy)-2-(3-(methoxymethoxy)phenyl)propan-2-ol
  参考文献：
  名称：

  Asymmetric synthesis of isobenzofuranone derivatives and their unique character as protein kinase Cα (PKCα) activators

  摘要：

  Efficient enantio-selective synthesis of conformationally constrained diacylglycerol analogues, 7-substituted isobenzofuranone derivatives, originally developed by us as PKC alpha ligands, was achieved by asymmetric dihydroxylation and gamma-lactone formation via ortho-lithiation and carboxylation. A series of derivatives having straight and/or branched side chains were synthesized and evaluated, and low-nanomolar-concentration affinity ligands and highly potent PKC alpha activators were found among them. These potent ligands induced phenotypic change of K562 cells, which is characteristic of PKC activators. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2009.03.069
• 作为产物：
  描述：

  1-(Methoxymethoxy)-3-(3-phenylmethoxyprop-1-en-2-yl)benzene 在 potassium osmate(VI) dihydrate 、 potassium carbonate 、 氢化奎宁 1,4-(2,3-二氮杂萘)二醚 、 potassium hexacyanoferrate(III) 作用下， 以 水 、 叔丁醇 为溶剂， 以54%的产率得到(2S)-2-[3-(methoxymethoxy)phenyl]-3-phenylmethoxypropane-1,2-diol
  参考文献：
  名称：

  Asymmetric synthesis of isobenzofuranone derivatives and their unique character as protein kinase Cα (PKCα) activators

  摘要：

  Efficient enantio-selective synthesis of conformationally constrained diacylglycerol analogues, 7-substituted isobenzofuranone derivatives, originally developed by us as PKC alpha ligands, was achieved by asymmetric dihydroxylation and gamma-lactone formation via ortho-lithiation and carboxylation. A series of derivatives having straight and/or branched side chains were synthesized and evaluated, and low-nanomolar-concentration affinity ligands and highly potent PKC alpha activators were found among them. These potent ligands induced phenotypic change of K562 cells, which is characteristic of PKC activators. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2009.03.069